Maelfait Jonathan, Vercammen Elisabeth, Janssens Sophie, Schotte Peter, Haegman Mira, Magez Stefan, Beyaert Rudi
Unit of Molecular Signal Transduction in Inflammation, Department for Molecular Biomedical Research, VIB, B-9052 Ghent, Belgium.
J Exp Med. 2008 Sep 1;205(9):1967-73. doi: 10.1084/jem.20071632. Epub 2008 Aug 25.
The cytokine interleukin (IL)-1beta is a key mediator of the inflammatory response and has been implicated in the pathophysiology of acute and chronic inflammation. IL-1beta is synthesized in response to many stimuli as an inactive pro-IL-1beta precursor protein that is further processed by caspase-1 into mature IL-1beta, which is the secreted biologically active form of the cytokine. Although stimulation of membrane-bound Toll-like receptors (TLRs) up-regulates pro-IL-1beta expression, activation of caspase-1 is believed to be mainly initiated by cytosolic Nod-like receptors. In this study, we show that polyinosinic:polycytidylic acid (poly[I:C]) and lipopolysaccharide stimulation of macrophages induces pro-IL-1beta processing via a Toll/IL-1R domain-containing adaptor-inducing interferon-beta-dependent signaling pathway that is initiated by TLR3 and TLR4, respectively. Ribonucleic acid interference (RNAi)-mediated knockdown of the intracellular receptors NALP3 or MDA5 did not affect poly(I:C)-induced pro-IL-1beta processing. Surprisingly, poly(I:C)- and LPS-induced pro-IL-1beta processing still occurred in caspase-1-deficient cells. In contrast, pro-IL-1beta processing was inhibited by caspase-8 peptide inhibitors, CrmA or vFLIP expression, and caspase-8 knockdown via RNAi, indicating an essential role for caspase-8. Moreover, recombinant caspase-8 was able to cleave pro-IL-1beta in vitro at exactly the same site as caspase-1. These results implicate a novel role for caspase-8 in the production of biologically active IL-1beta in response to TLR3 and TLR4 stimulation.
细胞因子白细胞介素(IL)-1β是炎症反应的关键介质,与急慢性炎症的病理生理学有关。IL-1β作为一种无活性的前体蛋白,在多种刺激下合成,该前体蛋白经半胱天冬酶-1进一步加工成为成熟的IL-1β,即该细胞因子的分泌型生物活性形式。虽然膜结合Toll样受体(TLR)的刺激会上调前体IL-1β的表达,但半胱天冬酶-1的激活被认为主要由胞质内Nod样受体启动。在本研究中,我们发现聚肌苷酸:聚胞苷酸(poly[I:C])和脂多糖对巨噬细胞的刺激分别通过由TLR3和TLR4启动的含Toll/IL-1受体结构域的衔接蛋白诱导干扰素-β依赖性信号通路诱导前体IL-1β的加工。RNA干扰(RNAi)介导的细胞内受体NALP3或MDA5的敲低并不影响poly(I:C)诱导的前体IL-1β加工。令人惊讶的是,poly(I:C)和脂多糖诱导的前体IL-1β加工在半胱天冬酶-1缺陷细胞中仍然发生。相反,半胱天冬酶-8肽抑制剂、CrmA或vFLIP过表达以及通过RNAi敲低半胱天冬酶-8均抑制了前体IL-1β加工,表明半胱天冬酶-8起重要作用。此外,重组半胱天冬酶-8能够在体外与半胱天冬酶-1完全相同的位点切割前体IL-1β。这些结果表明半胱天冬酶-8在响应TLR3和TLR4刺激产生生物活性IL-1β中具有新的作用。